These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22236242)

  • 1. Inflammatory bowel disease and ADAM17 deletion.
    Brandl K; Tomisato W; Beutler B
    N Engl J Med; 2012 Jan; 366(2):190; author reply 190. PubMed ID: 22236242
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory skin and bowel disease linked to ADAM17 deletion.
    Blaydon DC; Biancheri P; Di WL; Plagnol V; Cabral RM; Brooke MA; van Heel DA; Ruschendorf F; Toynbee M; Walne A; O'Toole EA; Martin JE; Lindley K; Vulliamy T; Abrams DJ; MacDonald TT; Harper JI; Kelsell DP
    N Engl J Med; 2011 Oct; 365(16):1502-8. PubMed ID: 22010916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally confirmed compound heterozygous ADAM17 missense loss-of-function variants cause neonatal inflammatory skin and bowel disease 1.
    Imoto I; Saito M; Suga K; Kohmoto T; Otsu M; Horiuchi K; Nakayama H; Higashiyama S; Sugimoto M; Sasaki A; Homma Y; Shono M; Nakagawa R; Hayabuchi Y; Tange S; Kagami S; Masuda K
    Sci Rep; 2021 May; 11(1):9552. PubMed ID: 33953303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into desmosome biology from inherited human skin disease and cardiocutaneous syndromes.
    Nitoiu D; Etheridge SL; Kelsell DP
    Cell Commun Adhes; 2014 Jun; 21(3):129-40. PubMed ID: 24738885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruption.
    Fréour T; Jarry A; Bach-Ngohou K; Dejoie T; Bou-Hanna C; Denis MG; Mosnier JF; Laboisse CL; Masson D
    Int J Mol Med; 2009 Jan; 23(1):41-8. PubMed ID: 19082505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
    Saibeni S; Spina L; Virgilio T; Folcioni A; Borsi G; de Franchis R; Cugno M; Vecchi M
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices.
    Kwak HI; Mendoza EA; Bayless KJ
    Matrix Biol; 2009 Oct; 28(8):470-9. PubMed ID: 19666115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression and in situ localization of ADAM17 during skin wound healing.
    Kawaguchi M; Suzuki T
    Int J Dermatol; 2014 Mar; 53(3):e229-31. PubMed ID: 23834487
    [No Abstract]   [Full Text] [Related]  

  • 9. ADAM17, shedding, TACE as therapeutic targets.
    Rose-John S
    Pharmacol Res; 2013 May; 71():19-22. PubMed ID: 23415892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells.
    Tsukamoto H; Tanida S; Ozeki K; Ebi M; Mizoshita T; Shimura T; Mori Y; Kataoka H; Kamiya T; Fukuda S; Higashiyama S; Joh T
    Inflamm Bowel Dis; 2013 Jun; 19(7):1365-73. PubMed ID: 23702712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ADAM10 and ADAM17 with potential roles in the spermatogenesis of the Chinese mitten crab, Eriocheir sinensis.
    Li Q; Xie J; He L; Wang Y; Duan Z; Yang H; Wang Q
    Gene; 2015 May; 562(1):117-27. PubMed ID: 25703701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM17 at the interface between inflammation and autoimmunity.
    Lisi S; D'Amore M; Sisto M
    Immunol Lett; 2014 Nov; 162(1 Pt A):159-69. PubMed ID: 25171914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-152 reduces human umbilical vein endothelial cell proliferation and migration by targeting ADAM17.
    Wu Y; Huang A; Li T; Su X; Ding H; Li H; Qin X; Hou L; Zhao Q; Ge X; Fang T; Wang R; Gao C; Li J; Shao N
    FEBS Lett; 2014 Jun; 588(12):2063-9. PubMed ID: 24813629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma.
    Liu Y; Wu C; Wang Y; Wen S; Wang J; Chen Z; He Q; Feng D
    Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):720-2. PubMed ID: 24969373
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression profile of ADAM10 and ADAM17 in allergic rhinitis.
    Chueh HW; Park SK; Hur DY; Bae WY
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population.
    Franke A; Ruether A; Wedemeyer N; Karlsen TH; Nebel A; Schreiber S
    Gut; 2006 Nov; 55(11):1679-80. PubMed ID: 17047129
    [No Abstract]   [Full Text] [Related]  

  • 17. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis.
    Murthy A; Shao YW; Narala SR; Molyneux SD; Zúñiga-Pflücker JC; Khokha R
    Immunity; 2012 Jan; 36(1):105-19. PubMed ID: 22284418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disintegrin domain of ADAM17 antagonises fibroblast‑carcinoma cell interactions.
    Trad A; Riese M; Shomali M; Hedeman N; Effenberger T; Grötzinger J; Lorenzen I
    Int J Oncol; 2013 May; 42(5):1793-800. PubMed ID: 23545805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability?
    Melenhorst WB; Visser L; Timmer A; van den Heuvel MC; Stegeman CA; van Goor H
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F781-90. PubMed ID: 19535569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pro-inflammatory cytokines on the production of soluble fractalkine and ADAM17 by HepG2 cells.
    Turner SL; Mangnall D; Bird NC; Blair-Zajdel ME; Bunning RA
    J Gastrointestin Liver Dis; 2010 Sep; 19(3):265-71. PubMed ID: 20922190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.